 Alexandra Mccubbrey
Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 9 | 2024 | 1548 | 1.880 |
Why?
| | Macrophages, Alveolar | 10 | 2025 | 392 | 1.250 |
Why?
| | Leukocytes, Mononuclear | 2 | 2024 | 558 | 0.870 |
Why?
| | Phagocytosis | 4 | 2021 | 379 | 0.840 |
Why?
| | Lung | 10 | 2024 | 4066 | 0.820 |
Why?
| | Folate Receptor 2 | 1 | 2023 | 9 | 0.820 |
Why?
| | Apoptosis | 5 | 2022 | 2557 | 0.790 |
Why?
| | Lung Injury | 2 | 2024 | 218 | 0.770 |
Why?
| | Cytophagocytosis | 1 | 2022 | 8 | 0.760 |
Why?
| | Pneumonia | 4 | 2023 | 638 | 0.750 |
Why?
| | Polyamines | 1 | 2022 | 40 | 0.740 |
Why?
| | Respiratory Hypersensitivity | 1 | 2021 | 69 | 0.690 |
Why?
| | CD11 Antigens | 2 | 2021 | 30 | 0.610 |
Why?
| | Pulmonary Fibrosis | 2 | 2024 | 400 | 0.610 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2018 | 22 | 0.570 |
Why?
| | Bleomycin | 2 | 2024 | 247 | 0.560 |
Why?
| | CD11b Antigen | 2 | 2021 | 62 | 0.550 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2024 | 653 | 0.530 |
Why?
| | Myeloid Cells | 1 | 2018 | 146 | 0.520 |
Why?
| | Phagocytes | 2 | 2017 | 100 | 0.510 |
Why?
| | Gene Deletion | 1 | 2018 | 393 | 0.500 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 62 | 0.500 |
Why?
| | Sirtuin 1 | 1 | 2015 | 31 | 0.490 |
Why?
| | Androstadienes | 2 | 2015 | 107 | 0.490 |
Why?
| | Antigens, CD | 1 | 2016 | 524 | 0.410 |
Why?
| | Down-Regulation | 2 | 2013 | 658 | 0.400 |
Why?
| | Collectins | 1 | 2012 | 12 | 0.390 |
Why?
| | Mice, Inbred C57BL | 11 | 2024 | 5792 | 0.370 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2012 | 188 | 0.360 |
Why?
| | Receptors, Immunologic | 1 | 2012 | 223 | 0.350 |
Why?
| | Mice, Transgenic | 4 | 2022 | 2182 | 0.340 |
Why?
| | Sequence Analysis, RNA | 3 | 2023 | 451 | 0.340 |
Why?
| | Pulmonary Alveoli | 2 | 2025 | 405 | 0.340 |
Why?
| | Mice | 12 | 2024 | 17843 | 0.330 |
Why?
| | Immune Tolerance | 1 | 2012 | 362 | 0.320 |
Why?
| | Monocytes | 2 | 2023 | 568 | 0.310 |
Why?
| | MicroRNAs | 1 | 2015 | 704 | 0.310 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2022 | 654 | 0.300 |
Why?
| | Lipopolysaccharides | 3 | 2024 | 886 | 0.300 |
Why?
| | Gene Expression | 4 | 2021 | 1505 | 0.290 |
Why?
| | Animals | 16 | 2025 | 37011 | 0.290 |
Why?
| | Flow Cytometry | 4 | 2022 | 1185 | 0.280 |
Why?
| | Lung Diseases | 1 | 2013 | 768 | 0.260 |
Why?
| | Pulmonary Emphysema | 2 | 2022 | 290 | 0.250 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2022 | 1042 | 0.230 |
Why?
| | Single-Cell Analysis | 2 | 2024 | 309 | 0.230 |
Why?
| | Healthy Volunteers | 2 | 2022 | 204 | 0.220 |
Why?
| | Spermine | 1 | 2022 | 27 | 0.190 |
Why?
| | Membrane Glycoproteins | 1 | 2024 | 501 | 0.190 |
Why?
| | Spermidine | 1 | 2022 | 19 | 0.190 |
Why?
| | Eosinophils | 2 | 2021 | 331 | 0.180 |
Why?
| | Lipid Metabolism | 1 | 2025 | 511 | 0.180 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 4 | 0.180 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 4 | 0.180 |
Why?
| | Lysophospholipase | 1 | 2021 | 10 | 0.180 |
Why?
| | Inflammation | 2 | 2023 | 2837 | 0.180 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2021 | 26 | 0.180 |
Why?
| | Immunomodulation | 1 | 2022 | 98 | 0.180 |
Why?
| | Cigarette Smoking | 1 | 2022 | 102 | 0.170 |
Why?
| | Humans | 17 | 2025 | 137514 | 0.170 |
Why?
| | Leukocyte Count | 1 | 2021 | 331 | 0.170 |
Why?
| | Mice, Knockout | 3 | 2022 | 3020 | 0.160 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 366 | 0.160 |
Why?
| | 5'-Nucleotidase | 1 | 2019 | 41 | 0.160 |
Why?
| | Glycoproteins | 1 | 2021 | 345 | 0.150 |
Why?
| | Organ Specificity | 2 | 2017 | 304 | 0.150 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1770 | 0.150 |
Why?
| | Breeding | 1 | 2018 | 62 | 0.140 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 47 | 0.140 |
Why?
| | Genotyping Techniques | 1 | 2018 | 75 | 0.140 |
Why?
| | Gene Targeting | 1 | 2018 | 83 | 0.140 |
Why?
| | Integrases | 1 | 2018 | 121 | 0.130 |
Why?
| | Recombination, Genetic | 1 | 2018 | 198 | 0.130 |
Why?
| | Disease Progression | 1 | 2024 | 2755 | 0.130 |
Why?
| | Male | 11 | 2024 | 67718 | 0.130 |
Why?
| | Fluticasone | 2 | 2015 | 90 | 0.120 |
Why?
| | Atherosclerosis | 1 | 2019 | 415 | 0.120 |
Why?
| | Smoking | 2 | 2013 | 1639 | 0.120 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2015 | 48 | 0.110 |
Why?
| | Female | 10 | 2024 | 73162 | 0.110 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 329 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2019 | 856 | 0.110 |
Why?
| | Acute Lung Injury | 1 | 2017 | 288 | 0.110 |
Why?
| | Transcriptional Activation | 1 | 2016 | 379 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 974 | 0.110 |
Why?
| | Disease Models, Animal | 5 | 2024 | 4295 | 0.110 |
Why?
| | Transfection | 1 | 2015 | 948 | 0.100 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 28 | 0.100 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1255 | 0.100 |
Why?
| | RNA | 1 | 2019 | 924 | 0.100 |
Why?
| | RNA, Double-Stranded | 1 | 2013 | 56 | 0.100 |
Why?
| | Genotype | 1 | 2018 | 1920 | 0.100 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2012 | 82 | 0.100 |
Why?
| | Phenotype | 3 | 2019 | 3205 | 0.100 |
Why?
| | Toll-Like Receptors | 1 | 2013 | 186 | 0.090 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 555 | 0.090 |
Why?
| | Immune System | 1 | 2012 | 177 | 0.090 |
Why?
| | Cells, Cultured | 3 | 2013 | 4206 | 0.080 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2013 | 328 | 0.080 |
Why?
| | Cytokines | 2 | 2017 | 2095 | 0.080 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 480 | 0.080 |
Why?
| | Homeostasis | 1 | 2013 | 622 | 0.080 |
Why?
| | Up-Regulation | 1 | 2012 | 846 | 0.080 |
Why?
| | Precision Medicine | 1 | 2013 | 426 | 0.080 |
Why?
| | Killer Cells, Natural | 1 | 2012 | 446 | 0.080 |
Why?
| | Aged | 4 | 2024 | 23798 | 0.080 |
Why?
| | Middle Aged | 5 | 2024 | 33355 | 0.080 |
Why?
| | Signal Transduction | 1 | 2022 | 5096 | 0.070 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 1092 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2013 | 917 | 0.060 |
Why?
| | Eye Proteins | 1 | 2024 | 92 | 0.060 |
Why?
| | X-Ray Microtomography | 1 | 2022 | 94 | 0.050 |
Why?
| | Fibrosis | 1 | 2024 | 552 | 0.050 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 11 | 0.050 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 8 | 0.050 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.050 |
Why?
| | Cell Size | 1 | 2021 | 91 | 0.040 |
Why?
| | Lectins | 1 | 2021 | 49 | 0.040 |
Why?
| | Leukocytes | 1 | 2022 | 311 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 277 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 595 | 0.030 |
Why?
| | Aorta, Thoracic | 1 | 2019 | 267 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 313 | 0.030 |
Why?
| | Cell Lineage | 1 | 2017 | 346 | 0.030 |
Why?
| | Chemokine CCL3 | 1 | 2015 | 17 | 0.030 |
Why?
| | Reactive Nitrogen Species | 1 | 2015 | 21 | 0.030 |
Why?
| | Chemokine CCL5 | 1 | 2015 | 43 | 0.030 |
Why?
| | Chemokine CXCL1 | 1 | 2015 | 76 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1238 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2015 | 120 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1740 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 2074 | 0.030 |
Why?
| | Interleukin-12 | 1 | 2015 | 121 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 514 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2017 | 488 | 0.030 |
Why?
| | Streptococcus pneumoniae | 1 | 2015 | 169 | 0.030 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 274 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2015 | 619 | 0.020 |
Why?
| | Metabolomics | 1 | 2017 | 679 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2017 | 1458 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2014 | 1150 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 845 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1242 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2017 | 2482 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2012 | 1271 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3292 | 0.020 |
Why?
| | Stem Cells | 1 | 2012 | 589 | 0.020 |
Why?
| | Cell Line | 1 | 2013 | 2852 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2838 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2615 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2012 | 1979 | 0.010 |
Why?
| | Adult | 2 | 2021 | 37821 | 0.010 |
Why?
| | Cohort Studies | 1 | 2013 | 5730 | 0.010 |
Why?
| | Prospective Studies | 1 | 2013 | 7598 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 13243 | 0.010 |
Why?
|
|
Mccubbrey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|